Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Established venous thromboembolism therapies: heparin, low molecular weight heparins, and vitamin K antagonists, with a discussion of heparin-induced thrombocytopenia.

Pendleton RC, Rodgers GM, Hull RD.

Clin Chest Med. 2010 Dec;31(4):691-706. doi: 10.1016/j.ccm.2010.07.003. Review.

PMID:
21047576
2.

Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review.

Akl EA, Barba M, Rohilla S, Terrenato I, Sperati F, Muti P, Schünemann HJ.

J Exp Clin Cancer Res. 2008 Jul 18;27:21. doi: 10.1186/1756-9966-27-21. Review.

3.

Update in the treatment of venous thromboembolism.

Garcia DA, Spyropoulos AC.

Semin Respir Crit Care Med. 2008 Feb;29(1):40-6. doi: 10.1055/s-2008-1047561. Review. Erratum in: Semin Respir Crit Care Med. 2008 Jun;29(3):319. Dosage error in article text.

PMID:
18302085
4.
5.

Unanswered questions in venous thromboembolism.

Weitz JI.

Thromb Res. 2009;123 Suppl 4:S2-S10. doi: 10.1016/S0049-3848(09)70135-5. Review.

PMID:
19303498
6.

Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?

Laux V, Perzborn E, Heitmeier S, von Degenfeld G, Dittrich-Wengenroth E, Buchmüller A, Gerdes C, Misselwitz F.

Thromb Haemost. 2009 Nov;102(5):892-9. doi: 10.1160/TH09-02-0134. Review.

PMID:
19888525
7.

Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.

Romera-Villegas A, Cairols-Castellote MA, Vila-Coll R, Martí-Mestre X, Colomé E, Iguaz I.

Ann Vasc Surg. 2010 Jul;24(5):628-39. doi: 10.1016/j.avsg.2009.08.006. Epub 2009 Nov 25. Review.

PMID:
19932949
8.

Initial treatment of venous thromboembolism.

Becattini C, Agnelli G, Emmerich J, Bura A, Weitz JI.

Thromb Haemost. 2006 Sep;96(3):242-50. Review.

PMID:
16953263
9.
10.

A review of the practical advantages of low molecular weight heparin in the treatment of cancer-related venous thromboembolism.

Rhodes S, Bond S.

Eur J Oncol Nurs. 2008 Dec;12(5):425-9. doi: 10.1016/j.ejon.2008.08.001. Epub 2008 Oct 7. Review.

PMID:
18842458
11.

Prevention of deep vein thrombosis in cancer patients.

Lee AY.

Semin Thromb Hemost. 2007 Oct;33(7):699-706. Review.

PMID:
18000798
12.

Prevention and treatment of venous thromboembolism.

Pineo GF, Hull RD.

Drugs. 1996 Jul;52(1):71-92. Review.

PMID:
8799686
13.

[Treatment of venous thromboembolic disease in cancer patients].

Farge-Bancel D, Florea L, Bosquet L, Debourdeau P.

Pathol Biol (Paris). 2008 Jun;56(4):220-8. doi: 10.1016/j.patbio.2008.02.007. Epub 2008 Apr 3. Review. French.

PMID:
18394821
14.

Guideline update. VTE disease: which agents, and when.

Holten KB, Merok J.

J Fam Pract. 2009 Mar;58(3):E1. Review. No abstract available.

PMID:
19284934
15.

[Prophylaxis and treatment of venous thromboembolism in cancer patients. Clinical value of low-molecular-weight heparins].

Kreher S, Riess H.

Internist (Berl). 2014 Apr;55(4):448-54. doi: 10.1007/s00108-014-3476-z. German.

PMID:
24599489
16.

Unfractionated heparin dosing for venous thromboembolism in morbidly obese patients: case report and review of the literature.

Myzienski AE, Lutz MF, Smythe MA.

Pharmacotherapy. 2010 Mar;30(3):324. doi: 10.1592/phco.30.3.324. Review.

PMID:
20180615
17.

How I treat pregnancy-related venous thromboembolism.

Middeldorp S.

Blood. 2011 Nov 17;118(20):5394-400. doi: 10.1182/blood-2011-04-306589. Epub 2011 Sep 14.

18.

Long-term anticoagulation: the prospects for alternatives to warfarin.

Ansell J.

Semin Vasc Surg. 2005 Sep;18(3):134-8. Review.

PMID:
16168888
19.

Treatment of venous thromboembolism in cancer patients.

Petralia GA, Kakkar AK.

Semin Thromb Hemost. 2007 Oct;33(7):707-11. Review.

PMID:
18000799
20.

Heparin and low-molecular-weight heparin therapy for venous thromboembolism: will unfractionated heparin survive?

Hull RD, Pineo GF.

Semin Thromb Hemost. 2004 Feb;30 Suppl 1:11-23. Review.

PMID:
15085462

Supplemental Content

Support Center